Direxion Daily S&P Biotech Bear 3X ETF
LABD
21 hedge funds and large institutions have $22.1M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.
396% more call options, than puts
Call options by funds: $14.5M | Put options by funds: $2.93M
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
11% more funds holding
Funds holding: 19 → 21 (+2)
9.74% less ownership
Funds ownership: 32.82% → 23.08% (-9.7%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
47% less capital invested
Capital invested by funds: $41.7M → $22.1M (-$19.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$4.57M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$2.92M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.47M |
| 4 |
ASM
AI-Squared Management
Hong Kong
|
+$1.58M |
| 5 |
BOCH
Blue Owl Capital Holdings
New York
|
+$1.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$23.2M |
| 2 |
VF
Virtu Financial
New York
|
-$2.26M |
| 3 |
Goldman Sachs
New York
|
-$1.48M |
| 4 |
IMC Chicago
Chicago,
Illinois
|
-$1.02M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$752K |
LABD Hedge Fund Activity: Q1 2024 in Review
21 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q1 2024, worth a combined $22.1M — down 47% from $41.7M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LABD positions and 6 closed out — a net gain of 2 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $4.57M. The largest seller was HRT Financial, exiting entirely with an estimated $23.2M sold.
- 21 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q1 2024, up from 19 in Q4 2023.
- Funds reported $22.1M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q1 2024, down 47% quarter-over-quarter.
- 8 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q1 2024 and 6 closed out, a net change of +2 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q1 2024 was Bank of America, an estimated $4.57M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q1 2024 was HRT Financial, an estimated $23.2M sold.
Based on aggregated 13F filings for Q1 2024.